620 related articles for article (PubMed ID: 22931571)
1. [Clinicopathological characteristics of malignant transformation in 85 cases of oral leukoplakia].
Gao Y; Guo ZL; Luo HY; Wang J
Zhonghua Kou Qiang Yi Xue Za Zhi; 2012 Jul; 47(7):410-3. PubMed ID: 22931571
[TBL] [Abstract][Full Text] [Related]
2. Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.
Warnakulasuriya S; Kovacevic T; Madden P; Coupland VH; Sperandio M; Odell E; Møller H
J Oral Pathol Med; 2011 Oct; 40(9):677-83. PubMed ID: 21762430
[TBL] [Abstract][Full Text] [Related]
3. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
[TBL] [Abstract][Full Text] [Related]
4. Long-term treatment outcome of oral premalignant lesions.
Holmstrup P; Vedtofte P; Reibel J; Stoltze K
Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
[TBL] [Abstract][Full Text] [Related]
5. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
Schepman KP; van der Meij EH; Smeele LE; van der Waal I
Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
[TBL] [Abstract][Full Text] [Related]
6. [Morphological classification of oral leukoplakia (author's transl)].
Burkhardt A; Seifert G
Dtsch Med Wochenschr; 1977 Feb; 102(7):223-9. PubMed ID: 836383
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of MAGE-A expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Ries J; Agaimy A; Vairaktaris E; Kwon Y; Neukam FW; Strassburg LH; Nkenke E
Int J Oncol; 2012 Sep; 41(3):1085-93. PubMed ID: 22751922
[TBL] [Abstract][Full Text] [Related]
8. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.
Hsue SS; Wang WC; Chen CH; Lin CC; Chen YK; Lin LM
J Oral Pathol Med; 2007 Jan; 36(1):25-9. PubMed ID: 17181738
[TBL] [Abstract][Full Text] [Related]
9. Epidemiology and correlation of the clinicopathological features in oral epithelial dysplasia: analysis of 173 cases.
Pereira Jdos S; Carvalho Mde V; Henriques AC; de Queiroz Camara TH; Miguel MC; Freitas Rde A
Ann Diagn Pathol; 2011 Apr; 15(2):98-102. PubMed ID: 21190879
[TBL] [Abstract][Full Text] [Related]
10. Oral verrucous hyperplasia: histologic classification, prognosis, and clinical implications.
Wang YP; Chen HM; Kuo RC; Yu CH; Sun A; Liu BY; Kuo YS; Chiang CP
J Oral Pathol Med; 2009 Sep; 38(8):651-6. PubMed ID: 19656267
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of cornulin, keratin 4, keratin 13 expression and grade of dysplasia for predicting malignant progression of oral leukoplakia.
Schaaij-Visser TB; Bremmer JF; Braakhuis BJ; Heck AJ; Slijper M; van der Waal I; Brakenhoff RH
Oral Oncol; 2010 Feb; 46(2):123-7. PubMed ID: 20036603
[TBL] [Abstract][Full Text] [Related]
12. E-cadherin as a potential biomarker of malignant transformation in oral leukoplakia: a retrospective cohort study.
von Zeidler SV; de Souza Botelho T; Mendonça EF; Batista AC
BMC Cancer; 2014 Dec; 14():972. PubMed ID: 25518919
[TBL] [Abstract][Full Text] [Related]
13. The relevance of EGFR overexpression for the prediction of the malignant transformation of oral leukoplakia.
Ries J; Vairaktaris E; Agaimy A; Bechtold M; Gorecki P; Neukam FW; Nkenke E
Oncol Rep; 2013 Sep; 30(3):1149-56. PubMed ID: 23784518
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of p53 and bcl-2 oncoprotein expression in precancerous lesions of the oral cavity.
Sulkowska M; Famulski W; Chyczewski L; Sulkowski S
Neoplasma; 2001; 48(2):94-8. PubMed ID: 11478700
[TBL] [Abstract][Full Text] [Related]
15. Malignant transformation of oral verrucous leukoplakia: a clinicopathologic study of 53 cases.
Liu W; Shen XM; Liu Y; Li J; Zhou ZT; Wang LZ
J Oral Pathol Med; 2011 Apr; 40(4):312-6. PubMed ID: 21342275
[TBL] [Abstract][Full Text] [Related]
16. Premalignant oral mucosal diseases.
Melrose RJ
J Calif Dent Assoc; 2001 Aug; 29(8):593-600. PubMed ID: 11577670
[TBL] [Abstract][Full Text] [Related]
17. [Oral medicine 8. Leukoplakia of the oral mucosa].
Schepman KP; van der Meij EH; de Visscher JG
Ned Tijdschr Tandheelkd; 2013; 120(7-8):384-90. PubMed ID: 23923441
[TBL] [Abstract][Full Text] [Related]
18. Pre-malignant lesions of the oral mucosa in a South African sample--a clinicopathological study.
Feller L; Altini M; Slabbert H
J Dent Assoc S Afr; 1991 May; 46(5):261-5. PubMed ID: 1962315
[TBL] [Abstract][Full Text] [Related]
19. Incorporation of differentiated dysplasia improves prediction of oral leukoplakia at increased risk of malignant progression.
Wils LJ; Poell JB; Evren I; Koopman MS; Brouns EREA; de Visscher JGAM; Brakenhoff RH; Bloemena E
Mod Pathol; 2020 Jun; 33(6):1033-1040. PubMed ID: 31896811
[TBL] [Abstract][Full Text] [Related]
20. Oral premalignant lesions: from a clinical perspective.
Amagasa T; Yamashiro M; Uzawa N
Int J Clin Oncol; 2011 Feb; 16(1):5-14. PubMed ID: 21225307
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
